Mutation of ERBB2 Provides a Novel Alternative Mechanism for the Ubiquitous Activation of RAS-MAPK in Ovarian Serous Low Malignant Potential TumorsNeoadjuvant chemotherapy for low-grade serous carcinoma of the ovary or peritoneum
